Brightlands, Maastricht Health Campus
Eureka Today, Expert: Jan Theys
In 1996 Jan Theys started his research as a PhD student in Leuven. In short: he uses the non-pathogenic bacterium Clostridium to ‘transport’ a chemotherapeutic drug to the tumor.
Read the article: